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E2F4/5 and p107 as Smad Cofactors Linking
the TGF Receptor to c-myc Repression
The TGF cytostatic program involves two classes of
immediate gene responses (Massague´ et al., 2000). One
includes activation of genes encoding the cyclin-depen-
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dent kinase (cdk) inhibitors p15Ink4b and p21Cip1/Waf1Howard Hughes Medical Institute
(Figure 1A). In combination with another cdk inhibitor,Memorial Sloan-Kettering Cancer Center
p27Kip1, mobilized from cdk4 bound storage, the induc-New York, New York 10021
tion of these proteins by TGF neutralizes the activity
of cdk2 and cdk4 during G1 phase of the cell cycle. In
the absence of this activity, the cdk substrates pRb,Summary
p107, and p130 remain bound to E2F transcription fac-
tors, preventing expression of E2F1-3 target genesSmad3 is a direct mediator of transcriptional activation
(Classon and Dyson, 2001; Mulligan and Jacks, 1998;by the TGF receptor. Its target genes in epithelial cells
Trimarchi and Lees, 2002). As these genes encode activ-include cyclin-dependent kinase inhibitors that gener-
ities required for DNA synthesis, their inhibition preventsate a cytostatic reponse. We defined how, in the same
cell cycle progression.context, Smad3 can also mediate transcriptional re-
The other class of cytostatic TGF responses includespression of the growth-promoting gene c-myc. A com-
repression of growth-promoting transcription factors,plex containing Smad3, the transcription factors E2F4/5
most notably Myc (Alexandrow and Moses, 1995; Mas-and DP1, and the corepressor p107 preexists in the
sague´ et al., 2000). In addition to acting as a transcrip-cytoplasm. In response to TGF, this complex moves
tional activator of growth and proliferation (Eisenman,into the nucleus and associates with Smad4, recogniz-
2001; Grandori et al., 2000), Myc also acts as a directing a composite Smad-E2F site on c-myc for repres-
inhibitor of p15Ink4b (Warner et al., 1999) and p21Cip1/sion. Previously known as the ultimate recipients of
Waf1 (Claassen and Hann, 2000). Thus, transcriptionalcdk regulatory signals, E2F4/5 and p107 act here as
repression of c-myc in response to TGF removestransducers of TGF receptor signals upstream of cdk.
growth-promoting functions while facilitating the induc-Smad proteins therefore mediate transcriptional acti-
tion of cdk inhibitors (Figure 1A; Seoane et al., 2001).vation or repression depending on their associated
TGF controls gene expression from the cell surfacepartners.
by assembling a receptor serine/threonine kinase com-
plex comprising subunits known as the type I receptorIntroduction
and type II receptor (Heldin et al., 1997; Massague´,
1998). Ligand-induced phosphorylation by the type IIGrowth factor signals control the expression of large
receptor enables the type I receptor to recognize andensembles of target genes through immediate effects
phosphorylate Smad2 and Smad3. Phosphorylation re-on transcriptional activation as well as repression. TGF
leases these proteins from cytoplasmic retention,signals mediated by Smad transcription factors are a
allowing their translocation into the nucleus and associ-case in point. Of several hundred immediate gene re-
ation with a related factor, Smad4. This assembly formssponses triggered by TGF in a given cell, over half
the core of transcriptional regulatory complexes.result in activation of the target and the rest result in
Work on genes that are activated by TGF or therepression (Chen et al., 2001; Zavadil et al., 2001). This
related factors activin, nodal, and bone morphogeneticraises the question of how a particular Smad complex
proteins (BMP) have revealed that an activated Smad
moving into the nucleus in response to TGF stimulation
complex recognizes regulatory elements in target genes
finds its way to the appropriate gene promoter and iden-
with the help of associated DNA binding cofactors (De-
tifies it as a predetermined target of activation or re- rynck et al., 1998; Massague´ and Wotton, 2000; Whit-
pression. man, 1998). Members of different families of transcrip-
This question presented itself in the analysis of the tion factors have been recently shown to function as
TGF cytostatic program. TGF fosters tissue growth Smad partners in this fashion. Combined, the DNA bind-
and morphogenesis during embryonic development ing ability of Smads and their partners provide each
(Bottinger et al., 1997). In the adult, however, TGFdeliv- particular complex with high affinity and specificity to-
ers cytostatic signals that help maintain tissue homeo- ward a particular target gene.
stasis (Massague´ et al., 2000). Epithelial cells of the skin, Little is known about what takes place between the
lung, liver, gut, pancreas, breast, prostate, and ovary, recognition of a particular gene by a Smad complex and
as well as hematopoietic, lymphoid, and endothelial the decision of whether to activate or repress that gene.
cells, are growth inhibited by TGF. Loss of respon- Smads can directly bind the transcriptional coactivators
siveness to TGF is a hallmark of many types of cancer, p300, CBP, and Smif, which are thought to mediate
occurring through mutational inactivation of TGF re- activation of at least some TGF target genes (Bai et
ceptors or Smads as well as selective losses of cyto- al., 2002; Feng et al., 1998; Janknecht et al., 1998; Pou-
static gene responses (Chen et al., 2001; Derynck et al., ponnot et al., 1998; Shen et al., 1998). Smads can inter-
2001; Massague´ et al., 2000). act with transcriptional corepressors as well, including
TGIF (Wotton et al., 1999) and the related proteins Ski
and SnoN (Luo et al., 1999; Sun et al., 1999). So far,1Correspondence: j-massague@ski.mskcc.org
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however, these corepressors have been shown to con-
strain the basal activity of Smad complexes rather than
mediate TGF-dependent gene repression responses.
Thus, the problem of how target gene repression is
decided over activation incorporates several long-stand-
ing questions about TGF action and its dependence on
cell type, signaling context, and target gene. These is-
sues remain unsolved for many other growth and differ-
entiation factors as well. The present identification of
E2F4/5 and p107 as signal cotransducers that enable a
Smad complex to recognize and repress c-myc sheds
light on some of these questions.
Results
Adjacent Smad and E2F Sites in c-myc Mediate
Repression by TGF
A TGF inhibitory element (TIE) located between
positions 92 and 63 relative to the P2 transcription
start site of c-myc mediates transcriptional repression
in response to TGF in human skin keratinocytes and
mammary epithelial cells (Figure 1B; Chen et al., 2001).
Used as a biotinylated double-stranded oligonucleotide
probe, this TIE recognizes a Smad3-Smad4 complex in
extracts from TGF-treated cell lines (Chen et al., 2001;
Yagi et al., 2002). We set out to identify the origin of this
complex and the components that enable it to selec-
tively bind to the TIE and mediate repression.
Mutational analysis of the TIE and surrounding region
did not reveal any canonical Smad binding site (GTCT
sequence) essential for the TGF response. However,
the TIE encompasses a canonical E2F site (Figure 1B;
Chen et al., 2001; Yagi et al., 2002). This site is flanked
5 by a sequence GGCT. Although this is an imperfect
Smad contact site, the Smad3-GTCT interaction admits
substitutions in the second base (Shi et al., 1998). We
investigated the role of these sites in HaCaT human
keratinocytes, a spontaneously immortalized cell line
that retains many properties of normal counterparts
(Boukamp et al., 1988) including a cytostatic response
to TGF (Reynisdo´ttir et al., 1995). Wild-type and mutant
versions of the –109/–3 region (fragment F) of c-mycFigure 1. Role of Adjacent Smad and E2F Sites and Rapid Binding
of Smads, E2F4/5, and p107 to the c-myc Promoter in Response were tested as transcriptional reporter constructs in
to TGF HaCaT cells (Figure 1C). Mutations targeting the GGCT
(A) Schematic representation of a TGF cytostatic program. sequence or the E2F site abolished the TGF response.
(B) Schematic representation of the human and rat c-myc promoter Mutations upstream of this sequence had no effect. The
and nucleotide sequence of the TIE element. P1 and P2 indicate the effects of these mutations were similar when tested in
transcription start sites, and the box marks the position of fragment F
the context of a construct containing three repeats ofused in luciferase reporter assays. Nucleotide sequence positions
the TIE (Figure 1D). Thus, the integrity of the E2F site is asare indicated relative to the P2 transcription start site. The E2F site
(yellow), the putative Smad binding site (blue), and the mutations important as that of the Smad site for TGF-dependent
targeting these sites and an upstream sequence are indicated. repression from the c-myc TIE.
(C and D) HaCaT cells were transfected with the indicated wild-type
(wt) or mutant TIE reporter constructs, treated with or without TGF
Rapid Binding of Smad3, Smad4, E2F4/5, and p107for 16–20 hr prior to lysis, and analyzed for luciferase activity. Re-
to the c-myc Promoter in Response to TGFporter constructs used include pFrag-F, pFrag-F-E2Fm, pFrag-F-
We carried out chromatin immunoprecipitation (ChIP)5m1, pFrag-F-5m2, p3xTIE, 3xTIE-E2Fm, p3xTIE5m1, and
p3xTIE5m2. assays to determine if Smad proteins bind to the c-myc
(E) HaCaT cells were left untreated () or treated () with TGF promoter along with a corepressor E2F complex in re-
for 1 hr, chromatin immunoprecipitations were performed with the sponse to TGF. Smad2 and Smad3 are direct sub-
indicated antibodies, and PCR was performed with primers specific
strates of the TGF type I receptor kinase, and theirfor the c-myc promoter region harboring the TIE and primers speci-
phosphorylation enables association with Smad4 andfic for the -actin promoter as TGF unresponsive control.
translocation into the nucleus. Smad2 and Smad3 are
of nearly identical amino acid sequence except for the
presence of a unique insert in Smad2 that prevents its
Mechanism of TGF-Mediated c-myc Repression
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direct binding to DNA (Shi et al., 1998). ChIP assays
using anti-Smad2/3 or anti-Smad4 antibodies demon-
strated that Smad2/3 and Smad4 specifically bind to
the proximal region of the c-myc promoter within 1 hr
of TGF addition (Figure 1E).
The activity of E2F factors is determined by their asso-
ciation with transcriptional corepressors of the retino-
blastoma family, pRb, p107, and p130 (Classon and Dy-
son, 2001; Mulligan and Jacks, 1998; Trimarchi and
Lees, 2002). This association is inhibited by cdk-medi-
ated phosphorylation of pRb, p107, and p130. E2F1,
E2F2, and E2F3 function primarily as transcriptional acti-
vators that become inhibited by association with pRB.
In contrast, E2F4 and E2F5 act as transcriptional repres-
sors in association with p107 or p130. ChIP assays using
suitable antibodies demonstrated that p107, E2F4, and
E2F5 specifically bind to the c-myc promoter in re-
sponse to TGF (Figure 1E), whereas pRb, p130, and
E2F1-3 do not (Figure 1E and data not shown). Thus,
TGF induces rapid binding of Smad2/3, Smad4,
E2F4/5, and p107 to the c-myc promoter in vivo.
The c-myc TIE Accommodates Smad3-Smad4
and E2F4-DP Complexes
To determine if binding of these proteins to the c-myc
promoter occurs in the TIE region, we conducted DNA
precipitation (DNAP) assays using biotinylated double-
stranded TIE oligonucleotides. The wild-type TIE probe
precipitated endogenous Smad3 and Smad4 from
TGF-treated cells but not control cells (Figure 2A).
Smad2 was more abundant than Smad3 in the cells
Figure 2. TGF-Induced Binding of Smad3-Smad4 and E2F4-DP tobut was present only in trace amounts in the TIE DNA
the c-myc TIEprecipitates (Figure 2A, compare first and third lanes).
(A) HaCaT cells were incubated in the absence () or presence ()Thus, the TIE recognizes a Smad3-Smad4 complex in
of TGF for 1 hr. Cell lysates were incubated with the indicatedpreference over a Smad2-Smad4 complex. This is con-
wild-type (wt) or mutant (E2Fm, 5m1, and 5m2) biotinylated double-sistent with the observation that skin keratinocytes from
stranded TIE oligonucleotides. DNA bound proteins, were precipi-
Smad3/ mice are defective in cytostatic but not other tated by streptavidin-agarose and the presence of Smad2, Smad3,
TGF responses (Ashcroft et al., 1999). or Smad4 was detected by immunoblotting. Total HaCat cell extract
Smad binding to the TIE in the DNAP assays was (Lysate) was included as a reference.
(B) COS-1 cells were transfected with Flag-Smad3, HA-E2F4, anddiminished by mutations targeting the E2F site (Figure
HA-p107 expression constructs. Cells were treated with () or with-2A, E2Fm lane) as effectively as it was by mutations
out () TGF and subjected to sequential immunoprecipitation, DNAtargeting the Smad site (Figure 2A, 5m1 lane). When
pull-down (DNAP), and immunoblotting analyses as diagrammed
directly used on cell lysates, the TIE oligonucleotide on the left. Wild-type (TIE WT) and mutant (E2Fm) biotinylated TIE
precipitated different E2F proteins indiscriminately and oligonucleotides were used in the DNAP. The presence of Flag-
in a TGF-independent manner (data not shown). This Smad3, HA-E2F4, HA-p107, and DP1 in the DNAP was detected
with anti-Flag, anti-HA, or anti-DP1 antibodies.is not surprising because E2F-DP in a cell-free system
(C) The X-ray crystal structure of the Smad3 MH1 domain bound tocan unrestrictedly bind to consensus E2F sites (Buck
GTCT (Shi et al., 1998) and the DNA binding domains of E2F4 andet al., 1995; Lees et al., 1993; Zhang and Chellappan,
DP2 binding jointly to an E2F site (Zheng et al., 1999) were oriented
1995). However, when we first immunoprecipitated to match the disposition of the Smad and E2F sites on the c-myc
Smad3 from a transfected COS cell extract, resus- TIE. Orthogonal views of the resulting model are shown.
pended this precipitate, and subjected the sample to TIE
DNAP, we observed a TGF-dependent and -specific
interaction with E2F4 (Figure 2B). E2F family members binding domains bound to an E2F site (Zheng et al.,
1999) were oriented to match the disposition of thebind to E2F sites as heterodimers with DP1 or DP2
(Trimarchi and Lees, 2002). We observed a TGF-depen- Smad and E2F sites on the c-myc TIE (Figure 2C). In
the resulting model, the TIE can accommodate Smad3dent association of DP1 and p107 in the Smad-con-
taining TIE precipitates (Figure 2B). These results sug- and E2F4-DP2 without clashing with each other. In fact,
these proteins sit sufficiently close to establish protein-gest that a complex containing Smad3, E2F4, DP1, and
p107 binds rapidly to the c-myc TIE in response to TGF. protein interactions on the DNA. In particular, the region
comprising residues 106–114 in the long  helix of DP2To see if simultaneous binding of Smad and E2F to
the c-myc TIE is feasible from a structural standpoint, is positioned close to the loop between  helices 2 and
3 and the loop preceding the DNA-contacting  hairpinthe crystal structures of the Smad3 DNA binding domain
bound to GTCT (Shi et al., 1998) and the E2F4-DP2 DNA of Smad3.
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Figure 3. A Preexisting Smad3-E2F4/5-p107
Complex
(A) COS-1 cells were transfected with vectors
encoding the indicated Flag epitope-tagged
E2F proteins, HA epitope-tagged p107 and
p130, or nontagged Rb. The cells were
treated with () or without () TGF for 1 hr,
and lysates were precipitated with the indi-
cated anti-Smad antibodies or purified rabbit
IgG as a control. The immunoprecipitates
were subjected to immunoblotting with anti-
bodies specific for pRb or the indicated epi-
tope tags. Protein expression was assessed
by direct immunoblotting of total lysates
(Input).
(B) HaCaT cells were treated with () or with-
out () TGF for 1 hr prior to lysis, and immu-
noprecipitations were performed with the in-
dicated antibodies. Smad-associated E2F4
and p107 were detected by immunoblot
analysis.
(C) COS-1 cells were transfected with vectors
encoding HA-p107, Flag-E2F4, Flag-E2F5,
and/or Smad3 as indicated. Lysates were
subjected to immunoprecipitation with anti-
Flag antibodies. Immune complexes were
eluted and subjected to immunoprecipitation
with anti-HA antibody. The latter precipitate
was subjected to immunoblotting with anti-
HA to detect HA-p107, anti-Flag to detect
F-E2F4 or F-E2F5, and anti-Smad2/3 antise-
rum to detect Smad3. The expression of
transfected proteins was monitored by immu-
noblotting of total cell extracts (Input).
A Preexisting Smad3-E2F4/5-p107 Complex component of the p107-E2F4/5 complex establishes an
interaction with Smad3, we subjected these proteinsTo investigate the physical interactions of Smads with E2F
and pRb family members, we expressed epitope-tagged and relevant deletion constructs to immunoprecipita-
tion-immunoblotting analysis in transfected COS cells.versions of these proteins in COS cells and assessed
their ability to coimmunoprecipitate with endogenous In cells cotransfected with Smad3 and E2F4 or E2F5
vectors, the E2F proteins were detectable in Smad3Smads. E2F4, E2F5, and p107 specifically interacted
with Smad2/3, whereas E2F1, pRb, and p130 did not, immunoprecipitates, and vice versa (Figures 4A, 4B, 4D,
and 4E). Using deletion constructs, we mapped theeven when overexpressed (Figure 3A). TGF addition
had no effect on these interactions. Smad-interacting region to the N-terminal segment of
E2F4 (residues 1–99) and E2F5 (residues 1–132) (FiguresWe confirmed the ability of endogenous Smad pro-
teins to interact with endogenous E2F4 and p107 by 4D and 4E). This region includes the DNA binding do-
main, which forms a tight fold (Zheng et al., 1999), andimmunoprecipitation of HaCaT cell lysates with anti-
Smad2/3 and anti-Smad4 antibodies followed by anti- a short segment that connects with the DP dimerization
domain, which falls outside this region. The DNA bindingE2F4 or anti-p107 immunoblotting (Figure 3B). The
Smad2/3-p107 and Smad2/3-E2F4 interactions did not domain is highly conserved among E2F family members,
but contains small clusters of residues unique to E2F4require cell stimulation with TGF, while the Smad4-
p107 and Smad4-E2F interactions were solely observed and E2F5. Because Smad3 does not interact with E2F1,
we surmise that these clusters determine the specificityin the presence of TGF. A sequential immunoprecipita-
tion protocol showed that Smad3, flag-tagged E2F4 (or of the Smad3-E2F4/5 interaction.
Using Smad3 deletion constructs, we mapped theE2F5), and HA-tagged p107 can coexist in the same
complex (Figure 3C). Collectively, these results indicate E2F4/5 interacting region to the MH2 domain of Smad3
(Figures 4A and 4B). The MH2 domain is a tightly packedthat cells contain a preassembled Smad3-E2F4-p107
complex, and Smad4 is incorporated into this complex globular structure that also binds to the type I TGF
receptor (Huse et al., 2001; Lo et al., 1998), the Smadon TGF stimulation.
anchor for receptor activation SARA (Tsukazaki et al.,
1998; Wu et al., 2000), partner Smads (Qin et al., 2001;Independent Smad3-p107
and Smad3-E2F4/5 Contacts Shi et al., 1997; Wu et al., 2001a), DNA binding cofactors
(Chen et al., 1998; Randall et al., 2002), coactivators,p107 binds directly to the C-terminal region of E2F4 and
E2F5 (Classon and Dyson, 2001). To determine which and corepressors (Massague´ and Wotton, 2000). X-ray
Mechanism of TGF-Mediated c-myc Repression
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Figure 4. Smad3-p107 and Smad3-E2F4/5 Interaction Domains
(A–F) COS-1 cells were transfected with vectors encoding HA-E2F4, HA-E2F5, HA-p107, and/or Flag-Smad3 as indicated at the bottom of
each panel, together with the deletion constructs diagrammed at the top of each panel. Cell lysates were divided and immunoprecipitated
with the antibodies indicated at the top of each panel. Immunoprecipitates were analyzed by immunoblotting with the antibodies indicated
on the left of each panel. Expression of the proteins was monitored by immunoblotting of total cell extracts (Input).
(G) GST control or GST-Smad3 bound to glutathione beads were mixed with purified maltose binding protein (MBP)-fusion proteins (indicated
at top). MBP-fusion proteins bound to the beads were detected by immunoblotting with anti-MBP antibodies. The amount of each MBP-
fusion protein used in the GST pull-downs was monitored by immunoblot analysis of total cell extracts (Input).
(H) A schematic representation of protein-protein interactions within the Smad3-p107-E2F4/5 complex. The interacting domains are intercon-
nected by lines. Abbreviations: DNA, DNA binding domain of E2Fs; A and B, the two regions of the A/B domain.
crystal structures of Smad-Smad (Qin et al., 2001; Shi p107 (Figures 4C and 4F). Using deletion constructs, we
mapped the interacting regions to the MH2 domain ofet al., 1997; Wu et al., 2001a) and Smad-SARA com-
plexes (Wu et al., 2000) have revealed the involvement Smad3 and the N-terminal 180 amino acid region of p107.
This region is separate from the E2F-interacting regionof distinct MH2 domain surfaces in these interactions,
with an important contribution of the receptor-phos- of p107, which corresponds to the A/B domain (Classon
and Dyson, 2001). To determine if the Smad3-p107 andphorylated C-terminal tail to the interaction with Smad4
(Wu et al., 2001a). Smad3-E2F4/5 interactions are direct, we performed in
vitro interaction assays using purified, recombinant pro-We also detected an interaction between Smad3 and
Cell
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teins (Figure 4G). A GST (glutathione S-transferase)-Smad3 phorylated (electrophoretically slower) form of p107 is
fusion protein specifically bound the recombinant frag- underrepresented in Smad2/3 complexes, as seen by
ments p107(1–180), E2F4(1–168), and E2F5(1–201), but comparing Smad2/3-associated p107 with total p107
not the negative control p107(181–387). Therefore, Smad3 (Figure 6A). These observations raised questions about
establishes direct, independent contacts with specific the availability of p107-Smad3 complexes throughout
domains of p107 and E2F4/5. The three binary protein- the cell cycle and the ability of TGF to regulate c-myc
protein interactions involved in the Smad3-p107-E2F4/5 during periods beyond G1 phase. To address these
complex are depicted in Figure 4H. questions, we used MO-91 cells, a human acute myelog-
enous leukemia line that has a strong cytostatic re-
Cytoplasmic Smad3-E2F4/5-p107 Complex and sponse to TGF with downregulation of c-myc, as in
Its TGF-Dependent Nuclear Translocation epithelial cells (J. Scandura and S. Nimer, personal com-
Smad3 is accumulated in the cytoplasm until it becomes munication). MO-91 cells grow in suspension and there-
phosphorylated by the TGF receptor and moves into fore are suitable for centrifugal elutriation.
the nucleus (Heldin et al., 1997; Massague´, 1998). p107 Asynchronous MO-91 cultures were elutriated into
is present in both compartments (Trimarchi and Lees, fractions enriched for cells in G1, S, or G2/M phase
2002). Unlike E2Fs 1–3, which are constitutively nuclear, (Figure 6B, top). As judged by its electrophoretic mobil-
E2F4 and E2F5 contain a nuclear localization signal and ity, p107 was largely in the underphosphorylated form
a CRM1-dependent nuclear export signal and are also in the G1 cells and accumulated as the hyperphosphory-
present both in the cytoplasm and the nucleus (Gaubatz lated form in the S and G2/M cells (Figure 6B, p107).
et al., 2000). Therefore, the subcellular distribution of However, some underphosphorylated p107 was present
these proteins is compatible with the notion that a throughout the cell cycle. Indeed, Smad2/3 was associ-
Smad3-p107-E2F4/5 complex could reside in the cyto- ated with underphosphorylated p107 during S phase
plasm awaiting TGF receptor-mediated activation. This (Figure 6C). Consistent with the persistent availability of
was demonstrated by Smad2/3 immunoprecipitation underphosphorylated p107, incubation of the elutriated
from a HaCaT cytosolic fraction followed by anti-E2F4 fractions with TGF for 2 hr resulted in Myc downregula-
or anti-p107 immunoblotting (Figure 5B). The same re- tion regardless of the cell cycle phase (Figure 6B).
sult was obtained using a DNase I-treated sample of
the same cytosolic fractions (Figure 5B), eliminating the Cell Cycle-Independent Repression of c-myc
possibility that these protein interactions are bridged by In HaCaT cells, TGF induces the upregulation of cdk
contaminating DNA. inhibitors p15Ink4b and p21Cip1/Waf1, which contrib-
Quantitation of the endogenous p107 in HaCaT cell utes to cdk inhibition and accumulation of underphos-
lysates and Smad2/3 immunoprecipitates revealed that phorylated pRb (Reynisdo´ttir et al., 1995). This might
only between 1.0% and 1.7% of the total p107 was secondarily lead to repression of c-myc along with many
bound to Smad2/3. Movement of such a small propor- other genes (Ren et al., 2002). Therefore, we determined
tion into the nucleus in response to TGF would not whether p15 and p21 induction and cdk inhibition play
significantly affect the overall distribution of p107 in the any role in the rapid downregulation of c-myc by TGF.
cell (Figure 5A). In order to visualize a TGF- and Smad3- Treatment of HaCaT cells with cycloheximide, a protein
dependent translocation of endogenous p107 into the synthesis inhibitor, before TGF addition did not block
nucleus, we overexpressed Smad3 in COS cells and c-myc downregulation by TGF (Figure 6D), suggesting
assessed the distribution of the proteins by immunofluo- that synthesis of cdk inhibitors is not required for this
rescence. COS cells have the added advantage that response. Next, we examined the kinetics of the c-myc
their endogenous p107 is largely nuclear in contrast to
response, the p15 and p21 induction, and the cdk inhibition
the more even distribution seen in HaCaT cells (Figure
in TGF-treated HaCaT cells. c-myc was downregulated
5A). In the absence of TGF, cells overexpressing Flag-
within 1 hr of TGF addition, which is much faster thantagged Smad3 showed a higher level of endogenous
the accumulation of p15 or p21 or the progressive inhibi-p107 in the cytoplasm than did their untransfected
tion of cdk2 kinase activity in these cells (Figure 6E).neighbors (Figure 5C). TGF addition reduced the level
We also examined the effect of p15 induction andof cytoplasmic Flag-Smad3 and that of cytoplasmic
cdk2 inhibition on c-myc expression using a mink lungp107 in the same cells (Figure 5C). Thus, a high level of
epithelial cell line Mv1Lu-tet-p15 that expresses ectopicSmad3 in the cytoplasm displaced endogenous p107
p15 in a tetracycline-regulated fashion (Reynisdo´ttir andout of the nucleus, and TGF addition forced this p107
Massague´, 1997). Induction of ectopic p15 caused aback into the nucleus.
progressive inhibition of cdk2 without downregulatingOverexpression of the Smad binding region (N-ter-
c-myc, at least in the short term (first 12 hr; Figure 6F).minal 180 amino acids) of p107 reduced the interaction
In contrast, TGF addition to the same cells immediatelybetween p107 and Smad3 with little effect on the E2F4-
led to c-myc downregulation. These data demonstratep107 interaction (Figure 5D). Overexpression of this con-
that induction of cdk inhibitors or cdk inhibition per sestruct inhibited the ability of Smad3 to force endogenous
do not mediate the rapid downregulation of c-myc seenp107 out of the nucleus (Figure 5C), arguing that the
in TGF-treated cells.observed redistribution of p107 is driven by its interac-
tion with Smad3.
Requirement of E2F4/E2F5 and p107 for c-myc
Repression by TGFMediation of the c-myc Response
Several experiments were conducted to seek evidencethroughout the Cell Cycle
that the Smad-p107-E2F4/5 complex is required for thep107 is phosphorylated by cdk as the cell approaches
S phase (Classon and Dyson, 2001). The hyperphos- c-myc response to TGF. Reporter assays using the
Mechanism of TGF-Mediated c-myc Repression
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Figure 5. Subcellular Localization and Nuclear Translocation of p107 and Smad2/3
(A) HaCaT cells were incubated for 1 hr in the presence () or absence () of TGF (100 pM). Cytosolic (C) and nuclear fractions (N) were
prepared and subjected to immunoblot analysis with anti-p107 and anti-Smad2/3 antibodies. Immunoblotting for -tubulin and lamin A/C
served as markers for cytoplasmic and nuclear fractions, respectively. The underphosphorylated (p107) and hyperphosphorylated (pp107)
forms of p107 are indicated.
(B) Cytosolic fraction was prepared from HaCaT cells and treated with or without DNaseI prior to Smad2/3 immunoprecipitation. Smad-
associated p107 and E2F4 were detected by immunoblotting. Immunoblot analysis of lamin A/C controlled for the purity of the cytosolic
fraction when compared to total cell lysate (Total). Plasmid DNA was added to lysates to monitor the efficiency of DNAaseI digestion.
(C) COS-1 cell cultures were transfected with or without the indicated vectors. Two days after transfection, cells were incubated in the presence
() or absence () of TGF for 1 hr and then subjected to immunofluorescence analysis with affinity-purified anti-Smad2/3 or anti-p107
antibodies to localize transfected Smad3 and endogenous p107, respectively. Nuclei were visualized by DNA staining with DAPI.
(D) COS-1 cells were transfected with vectors encoding Flag-E2F4, Flag-Smad3, and/or HA-p107(1–180), as indicated. Lysates were subjected
to immunoprecipitation with an anti-Flag antibody. The E2F4 or Smad3-associated endogenous p107 (endo-p107) was detected by immunoblot
analysis. The expression of transfected proteins was monitored by immunoblotting of total cell extracts (Input).
Smad-interacting regions of p107 and E2F4 as domi- (Figure 7A). Furthermore, TGF treatment caused a rapid
decrease in c-myc mRNA levels in T cells from wild-typenant-negative constructs showed that these constructs
attenuated the downregulation of the c-myc promoter, and p130/ mice but not T cells from p107/ mice
(Figure 7B). siRNA-mediated depletion of E2f4 or E2f5whereas the homologous region of E2F1 had no effect
Cell
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Figure 6. Smad3 Association with p107 and
Mediation of the c-myc Response throughout
the Cell Cycle
(A) Lysates from TGF-stimulated HaCaT
cells were immunoprecipitated with anti-
Smad2/3 or anti-p107 antibodies as indi-
cated. The immunoprecipitates were left un-
treated or treated with protein phosphatase,
and the presence of p107 was detected by
immunoblotting with anti-p107 antibodies.
The underphosphorylated (p107) and hyper-
phosphorylated (pp107) forms of p107 are in-
dicated.
(B) Exponentially growing MO-91 cells were
subjected to elutriation. The cell cycle distri-
bution was determined by flow cytometry of
samples from each fraction and from a con-
trol unfractionated culture (top). The fractions
were left untreated or treated with TGF for
2 hr and then subjected to immunoblotting
with the antibodies indicated on the left.
(C) Samples from the S phase fractions shown
in (B) were subjected to anti-Smad2/3 immuno-
precipitation followed by anti-p107 Western
immunoblotting. p107 precipitates from
asynchronous MO-91 cultures were used as
a source of underphosphorylated (p107) and
hyperphosphorylated (pp107) markers.
(D) HaCaT cells were treated with or without
10 g/ml cycloheximide (CHX) for 1 hr and
subsequently with () or without () TGF for
an additional 1 hr. Total RNA was isolated,
and the RNA level of c-myc and GAPDH were
detected by Northern blot analysis.
(E) HaCaT cells were treated with TGF for
the indicated times. Lysates and total RNA
were prepared and the protein level of p15,
p21, and Cdk2 and the RNA level of c-myc
and GAPDH were determined by immu-
noblotting and Northern blot. Cdk2-associ-
ated kinase activity was examined in Cdk2
immunoprecipitates using a GST-Rb fusion
protein as a substrate.
(F) Mv1Lu cells engineered to conditionally overexpress p15 in the absence of tetracycline were withdrawal from tetracycline inhibition for
the indicated times and treated with () or without () TGF for an additional 1 hr. The protein level of p15 and Cdk2, the RNA level of c-myc
and GAPDH, and the Cdk2-associated pRb kinase activity were determined as in (E).
messages in HaCaT cells had little or no effect on the sidesteps the question of how transcriptional repression
of other genes is executed by the same mediators in thec-myc response to TGF. When combined, however,
the E2f4 and E2f5 siRNAs caused a marked inhibition same cells. Transcriptomic analyses reveal that many
immediate TGF gene responses are, in fact, repressionof this response (Figure 7C). Furthermore, cell treatment
with E2f4 and E2f5 siRNA inhibited the Smad2/3-p107 responses (Chen et al., 2001; Zavadil et al., 2001). Among
these, repression of c-myc has long been known as partinteraction (Figure 7D). These results provide strong ge-
netic evidence for the importance and specificity of of the cytostatic effect of TGF (Alexandrow and Moses,
1995). Thus, questions arise about the basis for thep107, E2F4/5, and their contacts with Smad3 in the
c-myc response to TGF. choice of repression over activation when Smads bind
to a target gene.
The present work addresses some of these questions.
Discussion
By identifying E2F4/5 and DP1 as the DNA binding part-
ners of Smad3 and Smad4 in c-myc promoter recogni-
Current models of TGF action envision that receptor-
tion and p107 as the corepressor jointly recruited by
activated Smad proteins move into the nucleus, recruit
these proteins, the present results delineate a process
transcriptional coactivators, and associate with a host
of gene repression by TGF.
of DNA binding cofactors, generating different transcrip-
tional complexes, each with high affinity and specificity
toward a particular gene or set of genes (Massague´ et A Role for E2F4/5 and p107 as Cotransducers
of TGF Signalsal., 2000; Whitman, 1998). Several such complexes have
been identified and shown to mediate transcriptional The role of E2F4/5 and p107 as cotransducers of TGF
receptor signals suggested by our results is in contrastactivation of important genes. This model, however,
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Figure 7. Requirement of E2F4 and E2F5 for the Downregulation of c-myc Transcription by TGF
(A) HaCaT cells were transfected with the indicated reporter and expression constructs, treated with () or without () TGF, and analyzed
for luciferase activity. Constructs used were pFrag-F, pHA-E2F1(96–205), pHA-E2F4(1–99), and pHA-p107(1–180).
(B) Positive selection of mouse CD90(Thy 1.2) T cells was assessed by FACs analysis using anti-CD3 antibody. The positive fraction from
wt, p107/, and p130/ was found to contain 70%, 63%, and 61% CD3-positive T cells, respectively. T cells were cultured for 48 hr in wells
coated with 1.0 g/ml of anti-mouse CD3 antibody to facilitate activation and were incubated for an additional 2 hr in the absence () or
presence () of TGF (100 pM). The levels of c-myc message were detected by Northern blot analysis from total RNA, and the membrane
was subsequently reprobed for GAPDH as a loading control. Quantitation of normalized c-myc mRNA levels are shown as the percent relative
to T cells cultured in the absence of TGF.
(C) HaCaT cells were transfected with siRNA-targeting E2F4 or E2F5 alone or in combination. After 60 hr, transfected and mock-transfected
HaCaT cells were incubated in the presence () or absence () of TGF for 2 hr. Total RNA was isolated and the mRNA levels of c-myc,
E2f4, and E2f5 were detected by Northern blot and quantitated by densitometry.
(D) HaCaT cells were transfected with the indicated siRNA. Sixty hours after transfection, cells were treated with () or without () TGF prior
to lysis and Smad2/3 immunoprecipitation. Smad-associated p107 was detected by immunoblotting.
to the established role of E2Fs as ultimate recipients of with p107 or p130. p130-E2F4/5 complexes progres-
sively accumulate when cells undergo cdk inhibition andcell cycle regulatory signals that control the cdk/pRb/
E2F pathway. The role elucidated here places E2Fs as G1 arrest in response to mitogen deprivation (Moberg
et al., 1996; Takahashi et al., 2000; Tommasi and Pfeifer,cotransducers of TGF receptor signals that directly
repress c-myc and contribute to inhibiting cdk. Figure 1997; Vairo et al., 1995; Zwicker et al., 1996) or TGF
stimulation (Iavarone and Massague´, 1999; Yagi et al.,8 illustrates the relationship between these two roles of
E2Fs. 2002). p130-E2F4/5 complexes repress a large set of
cell cycle genes, thus maintaining a G0 state until cellsE2F1, -2, and -3 are essential for cell proliferation (Wu
et al., 2001b) and act as transcriptional activators of are stimulated to reenter the division cycle (Ren et al.,
2002; Takahashi et al., 2000).components required in S phase (Claassen and Hann,
2000; Gaubatz et al., 2000; Ren et al., 2002; Trimarchi The role of E2F4 and E2F5 as rapid mediators of c-myc
repression by TGF described here is unrelated, bothand Lees, 2002). The activity of E2F1-3 is inhibited by
binding of pRb and reactivated by cdk-mediated release temporally and mechanistically, to their role as repres-
sors in G0 (Figure 8). Our evidence shows that a poolfrom pRB. E2F4 and E2F5, on the other hand, act primar-
ily as transcriptional repressors, and do so in association of E2F4/5 and p107 is preassembled with Smad3 in the
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composition or function (Jayaraman and Massague,
2000). We now define one of those complexes as
Smad3-p107-E2F4/5. The fact that this complex exists
prior to TGF stimulation argues that Smad3 can be
preassembled into complexes of defined gene targeting
specificity. The pool of Smad3 in unstimulated cells may
include additional complexes with other partners to tar-
get different sets of genes upon TGF stimulation. The
responsiveness of a cell to TGFmay thus be configured
by preexisting Smad complexes and may be modified
by conditions affecting the abundance, activity, and/
or localization of Smad3 partners even before TGF
stimulation occurs. This represents a departure from
previous cases in which Smads achieve target gene
specificity once they meet DNA binding cofactors in the
nucleus (Chen et al., 1997; Germain et al., 2000; Hata
et al., 2000; Labbe´ et al., 1998). It is also worth noting
that both Smads and E2Fs are known to bind promiscu-
ously or constitutively to many sites in vitro that are
irrelevant or subject to considerable specific regulation
in vivo. We conclude that interactions between Smad3
and E2F4/5 allow each factor to contribute to the speci-
ficity of c-myc TIE regulation.
Context-Dependent c-myc Responsiveness
Myc downregulation is an important gene response in
TGF-induced cytostasis but is not uniformly present
in cells that are growth inhibited by TGF (Depoortere
et al., 2000; Sanchez et al., 1995) and may not be essen-
tial for cytostasis in all tissues. In fact, each of the com-
ponents of the Smad3-p107-E2F4/5 complex can be
genetically inactivated in the mouse without resulting
in dramatic hyperproliferative disorders. In all cases,
Figure 8. Schematic Representation of the TGF Pathway that Sig-
however, discreet hyperproliferative defects occur thatnals c-myc Repression
may be lethal depending on the genetic background.
TGF regulates gene expression by a canonical mechanism involv-
Smad3/mice develop normally but present with accel-ing phosphorylation of Smad3, which then binds Smad4, translo-
erated keratinocyte proliferation (Ashcroft et al., 1999),cates into the nucleus, and associates with DNA binding partners
and transcriptional coactivators (such as p300). This mechanism and in a different genetic background, they develop
has been demonstrated for various TGF target genes, and in the metastatic colon tumors with high penetrance (Zhu et
TGF cytostatic program, it applies to the induction of p15Ink4b al., 1998). p107 / mice are nearly normal in one genetic
and p21Cip1 cdk inhibitors. Discussions of the c-myc response and background (Sage et al., 2000) but show myeloid hyper-
downstream events are included in the main body of the text. In the
proliferation and a shorter cell cycle in another (LeCouterscheme, thin arrows represent direct effects or molecular interac-
et al., 1998). Mice deficient in E2f4 or E2f5 suffer diversetions, and block arrows represent multistep processes.
defects but are viable, whereas the combined inactiva-
tion of E2f4 and E2f5 leads to neonatal lethality and
cell resistance to growth arrest (Gaubatz et al., 2000).cytoplasm. TGF receptor activation enables nuclear
accumulation of this complex, incorporation of Smad4, Functional redundancy or compensation between family
members may account for the absence of more wide-and binding to the inhibitory element of c-myc. These
rapid events are completed within 1 hr of TGF addition spread hyperproliferative phenotypes in these various
cases.and can be triggered at any point during the cell cycle.
That is, the rapid c-myc response to TGF mediated by In cell systems studied here, E2f4 and E2f5 are func-
tionally redundant for the c-myc response to TGF.the Smad-E2F4/5-p107 complex is a cell cycle-indepen-
dent event contributing to, rather than deriving from, G1 However, p130 cannot substitute for p107. c-myc is
rapidly downregulated by TGF in p130-deficient T cellsarrest. The Smad-E2F4/5-p107 complex described here
might target additional genes in response to TGF. How- but not p107-deficient T cells. Although E2F4 and E2F5
can bind p130 (Trimarchi and Lees, 2002), we could notever, transcriptomic analyses of the TGF response in
E2f4- and E2f5-depleted HaCaT cells indicate that this detect p130 in Smad3 immunoprecipitates or on the c-myc
promoter in ChIP assays. In the c-myc response togroup of genes is very limited (our unpublished results).
TGF, at least, the function of p107 and p130 are not
redundant.A Preassembled myc-Targeting Complex with
Smads and E2Fs as DNA Binding Partners The present identification of the components of the
TGF-dependent c-myc repressor complex will allowIn the basal state, the endogenous Smad3 protein is
largely found in large complexes of previously unknown an analysis of this response and its regulation by signals
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eluted with Flag-tagged peptide as described (Bonni et al., 2001),that impinge on E2F4, E2F5, or p107. It will also allow
and the eluates were subjected to DNA precipitation assays.us to approach questions such as why the c-myc re-
sponse to TGF is present in some but not all epithelial
Immunoprecipitation, Immunoblotting, and Cdk2cells, is absent in fibroblasts that proliferate in response
Kinase Assays
to TGFduring wound healing, scar formation, and fibro- To detect endogenous-exogenous or exogenous-exogenous pro-
sis (Roberts et al., 1986), and is selectively lost in cancer tein complexes, COS-1 cells were transfected with expression plas-
cells that gain metastatic abilities in reponse to TGF mid(s) encoding the indicated proteins. Thirty-six hours post-
transfection, COS-1 cells were incubated for 1 hr in the presence(Chen et al., 2001).
or absence of TGF. Cells were lysed by sonication in HKMG buffer
(Chen et al., 2001), precleared with purified mouse or rabbit IgG,Experimental Procedures
and centrifuged at 13,000  g for 30 min. Supernatants were incu-
bated with antibodies and protein A/G beads for 3 hr at 4C on aCell Culture, Transfection, and Reporter Assays
rotating platform. Immunoprecipitates were separated by 8%–15%HaCaT, COS-1, and Mv1Lu-tet-p15 cells were maintained in DMEM
SDS-PAGE and transferred to PVDF membranes (Immobilon-P, Milli-medium and human leukemia MO-91 cells in RPMI. Media were
pore). Immunoblotting was carried out as previously described (Wot-supplemented with 10% FBS, penicillin, streptomycin, and fun-
ton et al., 1999). For detection of endogenous Smad3-associatedgizone. p15Ink4b induction in Mv1Lu-tet-p15 performed as pre-
proteins, 2  107 HaCaT cells or 2  108 MO-91 cells were treatedviously described (Reynisdo´ttir and Massague´, 1997) using freshly
with or without TGF for 1 hr and lysed by sonication in 3 ml ofreplated cells. HaCaT and COS-1 transfections were performed us-
HKMG buffer. Lysates were precleared with purified rabbit IgG anding LipofectAMINE (Invitrogen), according to the manufacturer’s in-
centrifuged at 13,000  g for 30 min. Immunoprecipitation and im-structions. Reporter assays were performed as previously described
munoblotting were performed as described above. To show the(Chen et al., 2001). For TGF treatment, we used 100 pM TGF1
presence of Smad3-E2F4/5-p107 trimeric complex, Flag-tagged im-(R&D Systems). To inhibit new protein synthesis, cells were treated
munoprecipitates were eluted with Flag-tagged peptide as de-with 10 g/ml of cycloheximide for 1 hr.
scribed (Bonni et al., 2001), and the eluates were subjected to a
second round of immunoprecipitation followed by immunoblot anal-
Plasmids ysis. Antibodies and agarose-conjugated antibodies used for the
To create expression vectors pHA-E2F1, pHA-E2F1(96–205), pHA- above analyses included anti-HA agarose (Sigma), anti-HA-Peroxi-
E2F4, pHA-E2F4(1–168), pHA-E2F4(169–413), pHA-E2F4(1–99), dase (3F10, Roche), anti-Flag M2 agarose (Sigma), anti-Flag M2-
pHA-E2F5, pHA-E2F5(1–201), pHA-E2F5(202–349), pHA-E2F5(1–132), peroxidase (Sigma), anti-E2F4 (Cat#05-312, Upstate Biotechnolo-
pHA-p107(1–180), p107(1–385), and p107(385–1068), the indicated gies), anti-DP1 (05-381, Upstate Biotechnologies), anti-p107 (sc-318,
coding regions were amplified from cDNA templates by polymerase Santa Cruz), anti-Rb (Cat#14001A, Pharmingen), anti-p15 (sc-612,
chain reaction (PCR) and inserted into the EcoRI/BamHI sites of a Santa Cruz), anti-p21 (MS-891-P, NeoMarkers), anti-cdk2 (Reynis-
modified pCMV5 plasmid containing two copies of an HA epitope do´ttir and Massague´, 1997), anti-Smad2/3 (Kretzschmar et al., 1999),
(Wotton et al., 1999). To generate the expression vectors pFlag- and anti-Smad4 (Calonge and Massague, 1999). Purified rabbit IgG
Smad3(1–145), pFlag-Smad3(146–425), pFlag-Smad3(220–425), pFlag- or mouse IgG was used as negative controls. For phosphatase
E2F1, pFlag-E2F4, and pFlag-E2F5, the corresponding coding re- treatment of cell extracts, lambda protein phosphatase was used
gions were PCR amplified and inserted into the EcoRI/BamHI sites as described by the manufacturer (New England Biolabs). Cdk2-
of a modified pCMV5 plasmid containing a Flag epitope (Wotton et associated Rb kinase activity was assayed as described previously
al., 1999). To construct the bacterial expression vectors pMBP- (Reynisdo´ttir et al., 1995).
p107(1–180), pMBP-p107(181–385), pMBP-E2F4(1–168), and pMBP-
E2F5(1–201), the specified coding regions were PCR amplified and GST Pull-Down Assay
cloned to the EcoRI/BamHI sites of pMAL-c2X (NEB). To create GST, GST-Smad3, MBP-p107(1–180), MBP-p107(181–385), MBP-
the reporter plasmids p3xTIE-E2Fm, p3xTIE5m1, and p3xTIE5m2, E2F4(1–168), and MBP-E2F5(1–201) were expressed in E. coli strain
mutant forms of the TGF inhibitory element (TIE) of c-myc (illus- BL21 and were purified as described (Truant et al., 1999). GST and
trated in Figure 1B) were synthesized as oligonucleotides and an- GST-Smad3 (6g and 3 g, respectively) were collected by glutathi-
nealed, and three tandem copies were then inserted into the BamHI one beads and mixed with 1g of each MBP-fusion protein in HKMG
site of pGL2-promoter (Promega). Reporter plasmids pFlag-F- buffer (Chen et al., 2001). The beads were washed and analyzed by
E2Fm, pFlag-F-TIE-5m1, and pFlag-F-TIE-5m2 were generated by immunoblotting.
site-directed mutagenesis using primer sets containing the afore-
mentioned mutations and pFrag-F as the template (Chen et al.,
Cell Fractionation2001). Mammalian expression vectors encoding Rb, HA-p107, and
HaCaT cells were incubated for 1 hr in the presence or absence ofHA-p130 were generously provided by A. Vidal and A. Koff (MSKCC,
TGF (100 pM) and collected by scraping into 1 phosphate-buf-New York). Reporter plasmid pGL2-3XTIE has been described pre-
fered saline (PBS). The cytoplasmic fraction was prepared usingviously (Chen et al., 2001).
NE-PERTM Nuclear and Cytoplasmic Extraction Reagents (Pierce),
following the manufacturer’s instructions. Following removal of the
Chromatin Immunoprecipitation Assay cytoplasmic fraction, the pellet was resuspended in 1.0 ml of lysis
ChIP assays were carried out as described (Takahashi et al., 2000). buffer (100 mM KCl, 10 mM HEPES [pH 7.9], 10% glycerol, 1 mM
Antibodies used were anti-Rb (sc-50, Santa Cruz), anti-p107 (sc-318, DTT, 5 mM MgCl2, 0.1% NP40, 10 mM NaF) containing 1 protease
Santa Cruz), anti-p130 (sc-317, Santa Cruz), anti-E2F4 (sc-1082x, inhibitors (CompleteTM Mini, EDTA free, Roche), 1 mM sodium ortho-
Santa Cruz), anti-E2F5 (sc-999, Santa Cruz), anti-Smad2/3 (Kretzsch- vanadate, and 1 mM -glycerolphosphate. The samples were vor-
mar et al., 1999), and anti-Smad4 (Calonge and Massague, 1999). texed briefly and subjected to two rounds of sonication. Lysates
Primer set 5-CTTTATAATGCGAGGGTCTGGAGC-3 and 5-GCTAT were stored on ice for 40 min and vortexed vigorously every 10 min
GGGCAAAGTTTCGTGGATG-3 were used to amplify a 400 bp during the incubation. The nuclear fraction was isolated following
region of the c-myc promoter harboring the TIE. The primer set centrifugation for 10 min at 14,000 rpm in a microcentrifuge. Anti-
used to amplify the promoter region of -actin was as described bodies specific to p107 (sc-318) and Lamin A/C (sc-7293; 1:500)
(Takahashi et al., 2000). were purchased from Santa Cruz Biotechnology. Detection of
-tubulin (T9026) was performed using antibodies obtained from
Sigma, and Smad2/3-specific rabbit polyclonal antibodies haveDNA Precipitation Assay
DNA precipitation assays were carried out as described previously been described previously (Kretzschmar et al., 1999). DNaseI treat-
ment of cytosolic fraction was performed using 10 U/ml of DNaseI(Chen et al., 2001). The sequences of wild-type and mutant TIE
oligonucleotides are illustrated in Figure 1B. To study the Smad3- at 4C for 30 min. Aliquots of lysates were incubated with 1 g of
a linealized DNA to monitor the efficiency of DNaseI.associated TIE complex, Flag-tagged immunoprecipitates were
Cell
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Immunofluorescence Analysis J.M. are a Research Associate and an Investigator, respectively, of
the Howard Hughes Medical Institute.COS-1 cells were transfected with or without FLAG-Smad3 and/
or HA-p107(1–180) using Fugene 6 Transfection Reagents (Roche
Molecular Biochemicals). Forty-eight hours after transfection, cells Received: February 20, 2002
were incubated in the presence or absence of TGF for 1 hr. Immu- Revised: June 3, 2002
nofluorescence staining was carried out essentially as previously
reported (Truant et al., 1999) with polyclonal rabbit anti-p107 (sc-
References318, Santa Cruz) and monoclonal mouse anti Smad2/3 (S66220, BD
Transduction Laboratories) antibodies. Images were obtained on a
Alexandrow, M.G., and Moses, H.L. (1995). Transforming growthNikon Eclipse TE300 microscope.
factor  and cell cycle regulation. Cancer Res. 55, 1452–1457.
Ashcroft, G.S., Yang, X., Glick, A.B., Weinstein, M., Letterio, J.L.,Cell Elutriation
Mizel, D.E., Anzano, M., Greenwell-Wild, T., Wahl, S.M., Deng, C.,MO-91 cells grown to a density of 5  106 cells/ml were subjected
and Roberts, A.B. (1999). Mice lacking Smad3 show acceleratedto elutriation as described (Koff et al., 1992). After elutriation, cells
wound healing and an impaired local inflammatory response. Nat.were recovered at room temperature for 30 min and were then
Cell Biol. 1, 260–266.treated with TGF for 2 hr at 37C. An aliquot of cells from each
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